Managers / Q2 2021 · view latest →
SITTNER & NELSON, LLC
CIK 0001846138 · 497 OAKWAY RD., SUITE 300, EUGENE, OR, 97401 · 541-636-4001
Summary
Sittner & Nelson, LLC reported $142M in U.S.-listed holdings across 396 positions for Q2 2021.
Its largest position, AAPL, represents 12.9% of the portfolio.
Compared with Q1 2021, the fund opened 10 new positions and exited 25.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 88.1% · $125M
- ETP · 4.6% · $7M
- Other · 3.3% · $5M
- ADR · 1.9% · $3M
- REIT · 1.6% · $2M
- Other · 0.4% · $634,000
Quarter-over-Quarter Changes full breakdown →
vs Q1 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| JELDJELD-WEN HLDG INC COM | NEW | +2.0K | 2.0K | +$53,000 | $53,000 |
| GMEGAMESTOP CORP NEW CLASS A | NEW | +135 | 135 | +$29,000 | $29,000 |
| AMC ENTMT HLDGS INC CL A COM | NEW | +500 | 500 | +$28,000 | $28,000 |
| ISHARES TR S&P SMALL-CAP 600 GROWTH ETF | NEW | +187 | 187 | +$25,000 | $25,000 |
| ISHARES TR MORNINGSTAR GROWTH ETF | NEW | +392 | 392 | +$25,000 | $25,000 |
| ISHARES TR RUSSELL 2000 VALUE ETF | NEW | +151 | 151 | +$25,000 | $25,000 |
| VRTXVERTEX PHARMACEUTICALS INC COM | NEW | +100 | 100 | +$20,000 | $20,000 |
| RIORIO TINTO PLC SPONSORED ADR ISIN#US7672041008 | NEW | +200 | 200 | +$17,000 | $17,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $274M | 573 | May 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $283M | 534 | Feb 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $275M | 485 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $249M | 507 | Aug 8, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $234M | 499 | May 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $231M | 493 | Feb 11, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $224M | 431 | Oct 31, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $203M | 456 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $199M | 499 | May 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $187M | 450 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $174M | 468 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $182M | 485 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $174M | 491 | May 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $164M | 463 | Feb 2, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $149M | 459 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $153M | 483 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $173M | 453 | May 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $172M | 444 | Feb 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $155M | 419 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $142M | 396 | Aug 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $134M | 411 | May 6, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $112M | 431 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.